The company specializes in creating implantable biologic stents that are surgically inserted to improve aqueous outflow and reduce intraocular pressure. They also offer advanced micro-interventional surgical technologies for ophthalmic medical devices. Founded in 2019 and headquartered in White Plains, New York, Iantrek focuses on developing technology for minimally invasive microinvasive glaucoma surgery.